129 related articles for article (PubMed ID: 9723953)
21. Inhibition of luteinizing hormone secretion by delta9-tetrahydrocannabinol in the ovariectomized rat: effect of pretreatment with neurotransmitter or neuropeptide receptor antagonists.
Murphy LL; Adrian BA; Kohli M
Steroids; 1999 Sep; 64(9):664-71. PubMed ID: 10503726
[TBL] [Abstract][Full Text] [Related]
22. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
23. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
24. Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms.
Perron RR; Tyson RL; Sutherland GR
Neuroreport; 2001 Dec; 12(17):3791-4. PubMed ID: 11726796
[TBL] [Abstract][Full Text] [Related]
25. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
27. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice.
Paronis CA; Nikas SP; Shukla VG; Makriyannis A
Behav Pharmacol; 2012 Dec; 23(8):802-5. PubMed ID: 23075707
[TBL] [Abstract][Full Text] [Related]
28. Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice.
Pertwee RG; Tavendale R
Br J Pharmacol; 1977 Aug; 60(4):559-68. PubMed ID: 907869
[TBL] [Abstract][Full Text] [Related]
29. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
30. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
31. Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.
Castelli MP; Madeddu C; Casti A; Casu A; Casti P; Scherma M; Fattore L; Fadda P; Ennas MG
PLoS One; 2014; 9(5):e98079. PubMed ID: 24844285
[TBL] [Abstract][Full Text] [Related]
32. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
33. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
34. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
[TBL] [Abstract][Full Text] [Related]
35. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
36. The pharmacological activity of inhalation exposure to marijuana smoke in mice.
Lichtman AH; Poklis JL; Poklis A; Wilson DM; Martin BR
Drug Alcohol Depend; 2001 Jul; 63(2):107-16. PubMed ID: 11376914
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
38. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
Shen M; Thayer SA
Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
[TBL] [Abstract][Full Text] [Related]
39. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
Englert LF; Ho BT; Taylor D
Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
Wu X; French ED
Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]